These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 32578856)
21. MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway. Zhou T; Xiang DK; Li SN; Yang LH; Gao LF; Feng C Cell Physiol Biochem; 2018; 49(2):798-815. PubMed ID: 30165354 [TBL] [Abstract][Full Text] [Related]
22. Sesamol inhibits proliferation, migration and invasion of triple negative breast cancer via inactivating Wnt/β-catenin signaling. Ma X; Hu X; Zhu Y; Jin H; Hu G; Ding L; Ning S Biochem Pharmacol; 2022 Dec; 206():115299. PubMed ID: 36244446 [TBL] [Abstract][Full Text] [Related]
23. DNER promotes epithelial-mesenchymal transition and prevents chemosensitivity through the Wnt/β-catenin pathway in breast cancer. Wang Z; Li Z; Wu Q; Li C; Li J; Zhang Y; Wang C; Sun S; Sun S Cell Death Dis; 2020 Aug; 11(8):642. PubMed ID: 32811806 [TBL] [Abstract][Full Text] [Related]
24. β-catenin promotes NLRP3 inflammasome activation via increasing the association between NLRP3 and ASC. Huang L; Luo R; Li J; Wang D; Zhang Y; Liu L; Zhang N; Xu X; Lu B; Zhao K Mol Immunol; 2020 May; 121():186-194. PubMed ID: 32244067 [TBL] [Abstract][Full Text] [Related]
25. Angiotensin(1-7) attenuated Angiotensin II-induced hepatocyte EMT by inhibiting NOX-derived H2O2-activated NLRP3 inflammasome/IL-1β/Smad circuit. Zhang LL; Huang S; Ma XX; Zhang WY; Wang D; Jin SY; Zhang YP; Li Y; Li X Free Radic Biol Med; 2016 Aug; 97():531-543. PubMed ID: 27445100 [TBL] [Abstract][Full Text] [Related]
26. Coenzyme Q Yang HL; Lin PY; Vadivalagan C; Lin YA; Lin KY; Hseu YC Arch Toxicol; 2023 Apr; 97(4):1047-1068. PubMed ID: 36847822 [TBL] [Abstract][Full Text] [Related]
27. NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway. Yin XF; Zhang Q; Chen ZY; Wang HF; Li X; Wang HX; Li HX; Kang CM; Chu S; Li KF; Li Y; Qiu YR Int J Oncol; 2018 Sep; 53(3):973-986. PubMed ID: 30015880 [TBL] [Abstract][Full Text] [Related]
28. miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer. Liu S; Wang Z; Liu Z; Shi S; Zhang Z; Zhang J; Lin H J Mol Cell Biol; 2018 Aug; 10(4):302-315. PubMed ID: 30053090 [TBL] [Abstract][Full Text] [Related]
29. Mesenchymal Stem Cells Antagonize IFN-Induced Proinflammatory Changes and Growth Inhibition Effects via Wnt/β-Catenin and JAK/STAT Pathway in Human Outer Root Sheath Cells and Hair Follicles. Lee YJ; Park SH; Park HR; Lee Y; Kang H; Kim JE Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925529 [TBL] [Abstract][Full Text] [Related]
30. Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin. Shen H; Yan W; Yuan J; Wang Z; Wang C J Exp Clin Cancer Res; 2019 Jun; 38(1):243. PubMed ID: 31174562 [TBL] [Abstract][Full Text] [Related]
31. Paricalcitol attenuates TGF-β1-induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 inflammasome. Ko J; Kang HJ; Kim DA; Ryu ES; Yu M; Lee H; Lee HK; Ryu HM; Park SH; Kim YL; Kang DH FASEB J; 2019 Feb; 33(2):3035-3050. PubMed ID: 30354670 [TBL] [Abstract][Full Text] [Related]
32. MiR-125b regulates the proliferation and metastasis of triple negative breast cancer cells via the Wnt/β-catenin pathway and EMT. Nie J; Jiang HC; Zhou YC; Jiang B; He WJ; Wang YF; Dong J Biosci Biotechnol Biochem; 2019 Jun; 83(6):1062-1071. PubMed ID: 30950326 [TBL] [Abstract][Full Text] [Related]
33. Leptin is upregulated in epididymitis and promotes apoptosis and IL-1β production in epididymal epithelial cells by activating the NLRP3 inflammasome. Lin N; Song X; Chen B; Ye H; Wang Y; Cheng X; Wang H Int Immunopharmacol; 2020 Nov; 88():106901. PubMed ID: 33182054 [TBL] [Abstract][Full Text] [Related]
34. Activating α7 nicotinic acetylcholine receptor inhibits NLRP3 inflammasome through regulation of β-arrestin-1. Ke P; Shao BZ; Xu ZQ; Chen XW; Wei W; Liu C CNS Neurosci Ther; 2017 Nov; 23(11):875-884. PubMed ID: 28941191 [TBL] [Abstract][Full Text] [Related]
35. The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer. Fatima I; El-Ayachi I; Taotao L; Lillo MA; Krutilina RI; Seagroves TN; Radaszkiewicz TW; Hutnan M; Bryja V; Krum SA; Rivas F; Miranda-Carboni GA PLoS One; 2017; 12(12):e0189864. PubMed ID: 29281678 [TBL] [Abstract][Full Text] [Related]
36. Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth. Bruchard M; Mignot G; Derangère V; Chalmin F; Chevriaux A; Végran F; Boireau W; Simon B; Ryffel B; Connat JL; Kanellopoulos J; Martin F; Rébé C; Apetoh L; Ghiringhelli F Nat Med; 2013 Jan; 19(1):57-64. PubMed ID: 23202296 [TBL] [Abstract][Full Text] [Related]
37. NLRP3 Promotes Glioma Cell Proliferation and Invasion via the Interleukin-1β/NF-κB p65 Signals. Xue L; Lu B; Gao B; Shi Y; Xu J; Yang R; Xu B; Ding P Oncol Res; 2019 May; 27(5):557-564. PubMed ID: 29769161 [TBL] [Abstract][Full Text] [Related]
38. P2X Yin J; Wang Y; Hu H; Li X; Xue M; Cheng W; Wang Y; Li X; Yang N; Shi Y; Yan S J Cell Mol Med; 2017 Nov; 21(11):2695-2710. PubMed ID: 28470940 [TBL] [Abstract][Full Text] [Related]
39. Interleukin-17 induces pyroptosis in osteoblasts through the NLRP3 inflammasome pathway in vitro. Lei L; Sun J; Han J; Jiang X; Wang Z; Chen L Int Immunopharmacol; 2021 Jul; 96():107781. PubMed ID: 34004438 [TBL] [Abstract][Full Text] [Related]
40. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production. Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]